Vitel Laboratorios Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

Vitel Laboratorios General Information

Description

Developer of cancer treatment drugs. The company engages in the development, research and production of novel cancer products and a proprietary vaccine technology distributed in the Mexican and Latin American market.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Monte Pelvoux 130 Piso 3
  • Lomas de Chapultepec, Miguel Hidalgo
  • Mexico City, 11000
  • Mexico
Primary Industry
Other Healthcare Services
Vertical(s)
Corporate Office
  • Monte Pelvoux 130 Piso 3
  • Lomas de Chapultepec, Miguel Hidalgo
  • Mexico City, 11000
  • Mexico

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitel Laboratorios Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vitel Laboratorios‘s full profile, request access.

Request a free trial

Vitel Laboratorios Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer treatment drugs. The company engages in the development, research and production of novel cancer pro
Other Healthcare Services
Mexico City, Mexico
11 As of 2016

Bethesda, MD
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vitel Laboratorios Competitors (16)

One of Vitel Laboratorios’s 16 competitors is CNBX Pharmaceuticals, a Corporation company based in Bethesda, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CNBX Pharmaceuticals Corporation Bethesda, MD
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Astellas Pharma Corporation Tokyo, Japan
Novo Nordisk Corporation Bagsvaerd, Denmark
Idorsia Pharmaceuticals Corporation Allschwil, Switzerland
You’re viewing 5 of 16 competitors. Get the full list »

Vitel Laboratorios Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitel Laboratorios Investments (1)

Vitel Laboratorios’s most recent deal was a Joint Venture with PharmaCielo México. The deal was made on 25-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PharmaCielo México 25-Jan-2019 Joint Venture Other Pharmaceuticals and Biotechnology
To view Vitel Laboratorios’s complete investments history, request access »

Vitel Laboratorios FAQs

  • When was Vitel Laboratorios founded?

    Vitel Laboratorios was founded in 2016.

  • Where is Vitel Laboratorios headquartered?

    Vitel Laboratorios is headquartered in Mexico City, Mexico.

  • What is the size of Vitel Laboratorios?

    Vitel Laboratorios has 11 total employees.

  • What industry is Vitel Laboratorios in?

    Vitel Laboratorios’s primary industry is Other Healthcare Services.

  • Is Vitel Laboratorios a private or public company?

    Vitel Laboratorios is a Private company.

  • What is Vitel Laboratorios’s current revenue?

    The current revenue for Vitel Laboratorios is .

  • Who are Vitel Laboratorios’s competitors?

    CNBX Pharmaceuticals, Genetix Biotherapeutics, Astellas Pharma, Novo Nordisk, and Idorsia Pharmaceuticals are some of the 16 competitors of Vitel Laboratorios.

  • When was Vitel Laboratorios acquired?

    Vitel Laboratorios was acquired on 10-Mar-2017.

  • Who acquired Vitel Laboratorios?

    Vitel Laboratorios was acquired by OncBioMune Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process